Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
Managing Ocular Toxicity in Multiple Myeloma Therapy
This chapter discusses the management of ocular toxicity linked to multiple myeloma treatments, emphasizing dosage strategies and patient monitoring. It features a case study on ibertamide, explores newer treatment options, and highlights the advantages of recent therapies over traditional methods.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
